In cases of Cutaneous Systemic Sclerosis, Nintedanib Slows Lung Function Decline.

Published Date: 01 Sep 2023

The potential of nintedanib as a treatment option for cutaneous systemic sclerosis was recently highlighted by a study that was published in the Rheumatology Journal.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Heavy Cannabis Use Tied to Increased Head and Neck Cancer Risk

2.

Early Results for Anorexia Nervosa with Psilocybin.

3.

Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer

4.

Colorectal Cancer Screening Uptake Tripled in 45-49 Age Group

5.

A new device enhances liquid biopsy.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot